350 related articles for article (PubMed ID: 17587091)
41. Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization.
Wallace AM; Daniel BL; Jeffrey SS; Birdwell RL; Nowels KW; Dirbas FM; Schraedley-Desmond P; Ikeda DM
J Am Coll Surg; 2005 Apr; 200(4):527-37. PubMed ID: 15804466
[TBL] [Abstract][Full Text] [Related]
42. Is axillary dissection needed in node-positive breast cancer?
Greenberg CC; Bafford AC; Golshan M
Expert Rev Anticancer Ther; 2008 Feb; 8(2):195-8. PubMed ID: 18279060
[TBL] [Abstract][Full Text] [Related]
43. Sentinel lymph node biopsy after neoadjuvant chemotherapy in inflammatory breast cancer.
Hidar S; Bibi M; Gharbi O; Tebra S; Trabelsi A; Korbi S; Bouaouina N; Ben Ahmed S; Khaïri H
Int J Surg; 2009 Jun; 7(3):272-5. PubMed ID: 19410665
[TBL] [Abstract][Full Text] [Related]
44. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
[TBL] [Abstract][Full Text] [Related]
45. Surgical treatment of early breast cancer in day surgery.
Marrazzo A; Taormina P; David M; Riili I; Lo Gerfo D; Casà L; Noto A; Mercadante S
Chir Ital; 2007; 59(5):687-91. PubMed ID: 18019641
[TBL] [Abstract][Full Text] [Related]
46. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
[TBL] [Abstract][Full Text] [Related]
47. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
[TBL] [Abstract][Full Text] [Related]
48. Sentinel node positivity rates with and without frozen section for breast cancer.
Arora N; Martins D; Huston TL; Christos P; Hoda S; Osborne MP; Swistel AJ; Tousimis E; Pressman PI; Simmons RM
Ann Surg Oncol; 2008 Jan; 15(1):256-61. PubMed ID: 17879116
[TBL] [Abstract][Full Text] [Related]
49. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
[TBL] [Abstract][Full Text] [Related]
50. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial.
Del Bianco P; Zavagno G; Burelli P; Scalco G; Barutta L; Carraro P; Pietrarota P; Meneghini G; Morbin T; Tacchetti G; Pecoraro P; Belardinelli V; De Salvo GL;
Eur J Surg Oncol; 2008 May; 34(5):508-13. PubMed ID: 17614245
[TBL] [Abstract][Full Text] [Related]
51. Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.
Park HS; Park S; Cho J; Park JM; Kim SI; Park BW
J Surg Oncol; 2013 Mar; 107(4):388-92. PubMed ID: 23007901
[TBL] [Abstract][Full Text] [Related]
52. Paget's disease in the era of sentinel lymph node biopsy.
Laronga C; Hasson D; Hoover S; Cox J; Cantor A; Cox C; Carter WB
Am J Surg; 2006 Oct; 192(4):481-3. PubMed ID: 16978954
[TBL] [Abstract][Full Text] [Related]
53. Sentinel node biopsy with intraoperative diagnosis in patients undergoing skin-sparing mastectomy and immediate breast reconstruction.
Meretoja TJ; Jahkola TA; Toivonen TS; Krogerus LA; Heikkilä PS; von Smitten KA; Leidenius MH
Eur J Surg Oncol; 2007 Dec; 33(10):1146-9. PubMed ID: 17462851
[TBL] [Abstract][Full Text] [Related]
54. Selective use of intraoperative sentinel lymph node pathological evaluation in breast cancer.
Gawlick U; Mone MC; Hansen HJ; Connors RC; Nelson EW
Am J Surg; 2008 Dec; 196(6):851-5; discussion 855-6. PubMed ID: 19095099
[TBL] [Abstract][Full Text] [Related]
55. The role of sentinel node biopsy in ductal carcinoma in situ of the breast.
Polom K; Murawa D; Wasiewicz J; Nowakowski W; Murawa P
Eur J Surg Oncol; 2009 Jan; 35(1):43-7. PubMed ID: 18723312
[TBL] [Abstract][Full Text] [Related]
56. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.
Monti S; Galimberti V; Trifiro G; De Cicco C; Peradze N; Brenelli F; Fernandez-Rodriguez J; Rotmensz N; Latronico A; Berrettini A; Mauri M; Machado L; Luini A; Paganelli G
Ann Surg Oncol; 2007 Oct; 14(10):2928-31. PubMed ID: 17674108
[TBL] [Abstract][Full Text] [Related]
57. National adoption of sentinel node biopsy for breast cancer: lessons learned from the Canadian experience.
Quan ML; Hodgson N; Lovrics P; Porter G; Poirier B; Wright FC
Breast J; 2008; 14(5):421-7. PubMed ID: 18657140
[TBL] [Abstract][Full Text] [Related]
58. Is Sentinel Lymph Node Biopsy Necessary for Ductal Carcinoma In Situ Patients Undergoing Mastectomy?
Miller-Ocuin JL; Howard-McNatt M; Levine EA; Chiba A
Am Surg; 2020 Aug; 86(8):955-957. PubMed ID: 32862671
[TBL] [Abstract][Full Text] [Related]
59. Use of reoperative sentinel lymph node biopsy in breast cancer patients.
Cox CE; Furman BT; Kiluk JV; Jara J; Koeppel W; Meade T; White L; Dupont E; Allred N; Meyers M
J Am Coll Surg; 2008 Jul; 207(1):57-61. PubMed ID: 18589362
[TBL] [Abstract][Full Text] [Related]
60. Pre-mastectomy sentinel lymph node biopsy: a strategy to enhance outcomes in immediate breast reconstruction.
Teven C; Agarwal S; Jaskowiak N; Park JE; Chhablani A; Seitz IA; Song DH
Breast J; 2013; 19(5):496-503. PubMed ID: 23773780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
